Fund profile
Tickers
JDOC
Fund manager
Total assets
$10.99 mm
Liabilities
$6.15 k
Net assets
$10.98 mm
Number of holdings
70.00
JDOC stock data
70 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Lilly(Eli) & Co | 921.29 k | 1.43 k shares | 8.39 | Common equity | Long | USA |
UNH Unitedhealth Group Inc | 876.10 k | 1.71 k shares | 7.98 | Common equity | Long | USA |
Novo Nordisk A/S, Class B
|
560.09 k | 4.90 k shares | 5.10 | Common equity | Long | Denmark |
REGN Regeneron Pharmaceuticals, Inc. | 525.13 k | 557.00 shares | 4.78 | Common equity | Long | USA |
AstraZeneca plc
|
488.02 k | 3.68 k shares | 4.44 | Common equity | Long | UK |
DHR Danaher Corp. | 380.26 k | 1.59 k shares | 3.46 | Common equity | Long | USA |
AMGN AMGEN Inc. | 358.57 k | 1.14 k shares | 3.27 | Common equity | Long | USA |
JNJ Johnson & Johnson | 355.62 k | 2.24 k shares | 3.24 | Common equity | Long | USA |
ABBV Abbvie Inc | 308.25 k | 1.88 k shares | 2.81 | Common equity | Long | USA |
Sanofi SA
|
305.64 k | 3.05 k shares | 2.78 | Common equity | Long | France |
CNC Centene Corp. | 299.21 k | 3.97 k shares | 2.72 | Common equity | Long | USA |
HCA HCA Healthcare Inc | 248.80 k | 816.00 shares | 2.27 | Common equity | Long | USA |
ABT Abbott Laboratories | 240.22 k | 2.12 k shares | 2.19 | Common equity | Long | USA |
MRK Merck & Co Inc | 221.03 k | 1.83 k shares | 2.01 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 213.44 k | 396.00 shares | 1.94 | Common equity | Long | USA |
EW Edwards Lifesciences Corp | 206.85 k | 2.64 k shares | 1.88 | Common equity | Long | USA |
MCK Mckesson Corporation | 175.46 k | 351.00 shares | 1.60 | Common equity | Long | USA |
Novartis AG (Registered)
|
172.80 k | 1.67 k shares | 1.57 | Common equity | Long | Switzerland |
Daiichi Sankyo Co. Ltd.
|
158.68 k | 5.30 k shares | 1.44 | Common equity | Long | Japan |
GSK plc
|
158.60 k | 8.02 k shares | 1.44 | Common equity | Long | UK |
BDX Becton Dickinson & Co. | 145.20 k | 608.00 shares | 1.32 | Common equity | Long | USA |
NTRA Natera Inc | 144.21 k | 2.19 k shares | 1.31 | Common equity | Long | USA |
JPMorgan U.S. Government Money Market Fund, Class IM | 140.94 k | 140.94 k shares | 1.28 | Short-term investment vehicle | Long | USA |
HUM Humana Inc. | 139.13 k | 368.00 shares | 1.27 | Common equity | Long | USA |
ISRG Intuitive Surgical Inc | 128.59 k | 340.00 shares | 1.17 | Common equity | Long | USA |
EVH Evolent Health Inc - Ordinary Shares | 114.38 k | 3.89 k shares | 1.04 | Common equity | Long | USA |
IRTC iRhythm Technologies Inc | 114.27 k | 954.00 shares | 1.04 | Common equity | Long | USA |
EXAS Exact Sciences Corp. | 109.41 k | 1.67 k shares | 1.00 | Common equity | Long | USA |
IQV IQVIA Holdings Inc | 109.32 k | 525.00 shares | 1.00 | Common equity | Long | USA |
ACHC Acadia Healthcare Company Inc | 107.69 k | 1.31 k shares | 0.98 | Common equity | Long | USA |
WST West Pharmaceutical Services, Inc. | 107.06 k | 287.00 shares | 0.97 | Common equity | Long | USA |
MRNA Moderna Inc | 106.41 k | 1.05 k shares | 0.97 | Common equity | Long | USA |
Lonza Group AG (Registered)
|
106.09 k | 217.00 shares | 0.97 | Common equity | Long | Switzerland |
ABMD Abiomed Inc | 103.85 k | 459.00 shares | 0.95 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Co. | 95.74 k | 1.96 k shares | 0.87 | Common equity | Long | USA |
Argenx SE
|
93.51 k | 248.00 shares | 0.85 | Common equity | Long | Netherlands |
FOLD Amicus Therapeutics Inc | 92.27 k | 7.42 k shares | 0.84 | Common equity | Long | USA |
DXCM Dexcom Inc | 92.10 k | 759.00 shares | 0.84 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies Inc | 91.11 k | 1.35 k shares | 0.83 | Common equity | Long | USA |
Sonova Holding AG (Registered)
|
91.09 k | 285.00 shares | 0.83 | Common equity | Long | Switzerland |
TWST Twist Bioscience Corp | 87.74 k | 2.71 k shares | 0.80 | Common equity | Long | USA |
ARVN Arvinas Inc | 85.24 k | 2.05 k shares | 0.78 | Common equity | Long | USA |
HOLX Hologic, Inc. | 80.99 k | 1.09 k shares | 0.74 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals Inc | 79.87 k | 1.26 k shares | 0.73 | Common equity | Long | USA |
INSP Inspire Medical Systems Inc | 79.08 k | 375.00 shares | 0.72 | Common equity | Long | USA |
EXEL Exelixis Inc | 78.73 k | 3.62 k shares | 0.72 | Common equity | Long | USA |
RVMD Revolution Medicines Inc | 78.01 k | 2.81 k shares | 0.71 | Common equity | Long | USA |
BPMC Blueprint Medicines Corp | 71.26 k | 896.00 shares | 0.65 | Common equity | Long | USA |
Sartorius AG (Preference)
|
67.49 k | 185.00 shares | 0.61 | Common equity | Long | Germany |
Royalty Pharma plc, Class A
|
62.88 k | 2.22 k shares | 0.57 | Common equity | Long | UK |
SYK Stryker Corp. | 58.71 k | 175.00 shares | 0.53 | Common equity | Long | USA |
BSX Boston Scientific Corp. | 56.93 k | 900.00 shares | 0.52 | Common equity | Long | USA |
ACCD Accolade Inc | 56.76 k | 5.01 k shares | 0.52 | Common equity | Long | USA |
ALGN Align Technology, Inc. | 55.87 k | 209.00 shares | 0.51 | Common equity | Long | USA |
HALO Halozyme Therapeutics Inc. | 51.55 k | 1.52 k shares | 0.47 | Common equity | Long | USA |
BIIB Biogen Inc | 51.31 k | 208.00 shares | 0.47 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals Inc | 49.29 k | 2.18 k shares | 0.45 | Common equity | Long | USA |
NARI Inari Medical Inc | 45.56 k | 800.00 shares | 0.41 | Common equity | Long | USA |
RLAY Relay Therapeutics Inc | 41.48 k | 4.48 k shares | 0.38 | Common equity | Long | USA |
IDXX Idexx Laboratories, Inc. | 40.69 k | 79.00 shares | 0.37 | Common equity | Long | USA |
Straumann Holding AG (Registered)
|
39.65 k | 261.00 shares | 0.36 | Common equity | Long | Switzerland |
ALNY Alnylam Pharmaceuticals Inc | 37.18 k | 215.00 shares | 0.34 | Common equity | Long | USA |
RGNX Regenxbio Inc | 30.36 k | 2.46 k shares | 0.28 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 30.24 k | 942.00 shares | 0.28 | Common equity | Long | USA |
SAGE Sage Therapeutics Inc | 23.56 k | 919.00 shares | 0.21 | Common equity | Long | USA |
RVNC Revance Therapeutics Inc | 18.50 k | 3.68 k shares | 0.17 | Common equity | Long | USA |
SLRN Acelyrin Inc | 17.05 k | 2.24 k shares | 0.16 | Common equity | Long | USA |
Sandoz Group AG
|
11.45 k | 334.00 shares | 0.10 | Common equity | Long | Switzerland |
VERV Verve Therapeutics Inc | 11.18 k | 1.03 k shares | 0.10 | Common equity | Long | USA |
ALLO Allogene Therapeutics Inc | 10.94 k | 3.11 k shares | 0.10 | Common equity | Long | USA |